+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Fluorescence In Situ Hybridization Probe Market by Technology, Application, Type, End-User, Product, Probe Design - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 180 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 6017509
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Fluorescence In Situ Hybridization Probe Market grew from USD 848.76 million in 2023 to USD 902.68 million in 2024. It is expected to continue growing at a CAGR of 7.92%, reaching USD 1.44 billion by 2030.

Fluorescence In Situ Hybridization (FISH) probes are critical diagnostic tools used in molecular cytogenetics to detect and localize the presence or absence of specific DNA sequences on chromosomes. The technology plays a vital role in various applications, particularly in cancer research, genetic disorder diagnosis, and chromosomal anomaly detection, making it indispensable for clinical laboratories and research institutions. The increasing prevalence of genetic disorders and cancers, coupled with advancements in personalized medicine, underscores the necessity for FISH probes. This market is witnessing significant growth due to the rising demand for targeted therapies and precision medicine, as well as the ongoing development of new and sophisticated probe technologies. However, challenges such as the high cost of FISH procedures, the complexity of interpretation, and the need for skilled professionals are limiting factors. Moreover, strict regulatory requirements and limited awareness in emerging regions also hinder market expansion.

The FISH probe market is buoyed by technological innovations, such as multiplexing capabilities and the development of automated systems, presenting opportunities for companies to cater to the evolving needs of both diagnostic and research applications. One of the key growth drivers is the increasing focus on oncology, where FISH probes are crucial for identifying chromosomal abnormalities and guiding treatment decisions. Companies can capitalize on these opportunities by investing in R&D to develop cost-effective and simpler probe solutions, enhancing the reach and accessibility of these advanced diagnostic tools.

Strategic recommendations include forming partnerships with healthcare providers and research centers to enhance product applications and support services. Simultaneously, a focus on emerging markets can offer untapped potential due to their growing healthcare infrastructure. Despite these opportunities, the market's competitive nature requires continuous innovation and differentiation. Overall, stakeholder collaborations and investment in digital health platforms to improve the efficiency and interpretation of FISH analyses remain potent avenues for growth and expansion in this dynamic market landscape.

Understanding Market Dynamics in the Fluorescence In Situ Hybridization Probe Market

The Fluorescence In Situ Hybridization Probe Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Increasing applications of fluorescence in situ hybridization probes in genetic disorder diagnosis and research
    • Growing demand for targeted therapies and personalized medicine boosting fluorescence probe market
    • Advancements in probe technology and automation enhancing accuracy and efficiency in laboratories
    • Rising investment in cancer research driving the utilization of innovative probe technologies
  • Market Restraints
    • High technical expertise and training required for accurate interpretation of FISH probe results
    • Limited availability of skilled personnel for the utilization and analysis of FISH probes
  • Market Opportunities
    • Technological advancements in medical imaging techniques elevate demand for high-precision FISH probes
    • Rising investment in research and development activities by biotechnology firms enhances market expansion
  • Market Challenges
    • Limited availability of skilled personnel for the utilization and analysis of FISH probes

Exploring Porter’s Five Forces for the Fluorescence In Situ Hybridization Probe Market

Porter’s Five Forces framework further strengthens the insights of the Fluorescence In Situ Hybridization Probe Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Fluorescence In Situ Hybridization Probe Market

External macro-environmental factors deeply influence the performance of the Fluorescence In Situ Hybridization Probe Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Fluorescence In Situ Hybridization Probe Market

The Fluorescence In Situ Hybridization Probe Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Fluorescence In Situ Hybridization Probe Market

The Fluorescence In Situ Hybridization Probe Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Fluorescence In Situ Hybridization Probe Market

The Fluorescence In Situ Hybridization Probe Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Fluorescence In Situ Hybridization Probe Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agilent Technologies, Bio-Rad Laboratories, Bio-Techne Corporation, Biosearch Technologies, Enzo Life Sciences, Exiqon, F. Hoffmann-La Roche, Geneco Biomedical Products, GeneCopoeia, GlaxoSmithKline, Horizon Diagnostics, LabCorp, Leica Biosystems, Merck Group, NeoGenomics Laboratories, OxFord Gene Technology, PerkinElmer, Thermo Fisher Scientific, and Zymo Research.

Market Segmentation & Coverage

This research report categorizes the Fluorescence In Situ Hybridization Probe Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Technology
    • DNA Probes
    • PNA Probes
    • RNA Probes
  • Application
    • Cancer Diagnosis
      • Hematological Malignancies
      • Solid Tumors
    • Drug Discovery
    • Genetic Disorders
    • Microbial Diagnostics
  • Type
    • Labeled Probes
    • Unlabeled Probes
  • End-User
    • Biotechnology Companies
    • Clinical Laboratories
    • Pharmaceutical Companies
    • Research Laboratories
  • Product
    • Fluorescent Dye Labeled Probes
    • Non-Fluorescent Dye Labeled Probes
      • FRET Probes
      • Quencher Probes
  • Probe Design
    • Dual-Color Probes
    • Multiplex Probes
    • Single-Color Probes
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing applications of fluorescence in situ hybridization probes in genetic disorder diagnosis and research
5.1.1.2. Growing demand for targeted therapies and personalized medicine boosting fluorescence probe market
5.1.1.3. Advancements in probe technology and automation enhancing accuracy and efficiency in laboratories
5.1.1.4. Rising investment in cancer research driving the utilization of innovative probe technologies
5.1.2. Restraints
5.1.2.1. High technical expertise and training required for accurate interpretation of FISH probe results
5.1.2.2. Limited availability of skilled personnel for the utilization and analysis of FISH probes
5.1.3. Opportunities
5.1.3.1. Technological advancements in medical imaging techniques elevate demand for high-precision FISH probes
5.1.3.2. Rising investment in research and development activities by biotechnology firms enhances market expansion
5.1.4. Challenges
5.1.4.1. Limited availability of skilled personnel for the utilization and analysis of FISH probes
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Fluorescence In Situ Hybridization Probe Market, by Technology
6.1. Introduction
6.2. DNA Probes
6.3. PNA Probes
6.4. RNA Probes
7. Fluorescence In Situ Hybridization Probe Market, by Application
7.1. Introduction
7.2. Cancer Diagnosis
7.2.1. Hematological Malignancies
7.2.2. Solid Tumors
7.3. Drug Discovery
7.4. Genetic Disorders
7.5. Microbial Diagnostics
8. Fluorescence In Situ Hybridization Probe Market, by Type
8.1. Introduction
8.2. Labeled Probes
8.3. Unlabeled Probes
9. Fluorescence In Situ Hybridization Probe Market, by End-User
9.1. Introduction
9.2. Biotechnology Companies
9.3. Clinical Laboratories
9.4. Pharmaceutical Companies
9.5. Research Laboratories
10. Fluorescence In Situ Hybridization Probe Market, by Product
10.1. Introduction
10.2. Fluorescent Dye Labeled Probes
10.3. Non-Fluorescent Dye Labeled Probes
10.3.1. FRET Probes
10.3.2. Quencher Probes
11. Fluorescence In Situ Hybridization Probe Market, by Probe Design
11.1. Introduction
11.2. Dual-Color Probes
11.3. Multiplex Probes
11.4. Single-Color Probes
12. Americas Fluorescence In Situ Hybridization Probe Market
12.1. Introduction
12.2. Argentina
12.3. Brazil
12.4. Canada
12.5. Mexico
12.6. United States
13. Asia-Pacific Fluorescence In Situ Hybridization Probe Market
13.1. Introduction
13.2. Australia
13.3. China
13.4. India
13.5. Indonesia
13.6. Japan
13.7. Malaysia
13.8. Philippines
13.9. Singapore
13.10. South Korea
13.11. Taiwan
13.12. Thailand
13.13. Vietnam
14. Europe, Middle East & Africa Fluorescence In Situ Hybridization Probe Market
14.1. Introduction
14.2. Denmark
14.3. Egypt
14.4. Finland
14.5. France
14.6. Germany
14.7. Israel
14.8. Italy
14.9. Netherlands
14.10. Nigeria
14.11. Norway
14.12. Poland
14.13. Qatar
14.14. Russia
14.15. Saudi Arabia
14.16. South Africa
14.17. Spain
14.18. Sweden
14.19. Switzerland
14.20. Turkey
14.21. United Arab Emirates
14.22. United Kingdom
15. Competitive Landscape
15.1. Market Share Analysis, 2023
15.2. FPNV Positioning Matrix, 2023
15.3. Competitive Scenario Analysis
15.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET RESEARCH PROCESS
FIGURE 2. FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 7. GLOBAL FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 9. GLOBAL FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 11. GLOBAL FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 13. GLOBAL FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 15. GLOBAL FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. GLOBAL FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY PROBE DESIGN, 2023 VS 2030 (%)
FIGURE 17. GLOBAL FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY PROBE DESIGN, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. AMERICAS FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. AMERICAS FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. UNITED STATES FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 21. UNITED STATES FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. ASIA-PACIFIC FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 23. ASIA-PACIFIC FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 26. FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 27. FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET DYNAMICS
TABLE 7. GLOBAL FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY DNA PROBES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY PNA PROBES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY RNA PROBES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY CANCER DIAGNOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY SOLID TUMORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY CANCER DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY MICROBIAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY LABELED PROBES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY UNLABELED PROBES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY FLUORESCENT DYE LABELED PROBES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY NON-FLUORESCENT DYE LABELED PROBES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY FRET PROBES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY QUENCHER PROBES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY NON-FLUORESCENT DYE LABELED PROBES, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY PROBE DESIGN, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY DUAL-COLOR PROBES, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY MULTIPLEX PROBES, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY SINGLE-COLOR PROBES, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY CANCER DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY NON-FLUORESCENT DYE LABELED PROBES, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY PROBE DESIGN, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 46. ARGENTINA FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 47. ARGENTINA FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 48. ARGENTINA FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY CANCER DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 49. ARGENTINA FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 50. ARGENTINA FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 51. ARGENTINA FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 52. ARGENTINA FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY NON-FLUORESCENT DYE LABELED PROBES, 2018-2030 (USD MILLION)
TABLE 53. ARGENTINA FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY PROBE DESIGN, 2018-2030 (USD MILLION)
TABLE 54. BRAZIL FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 55. BRAZIL FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 56. BRAZIL FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY CANCER DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 57. BRAZIL FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 58. BRAZIL FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 59. BRAZIL FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 60. BRAZIL FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY NON-FLUORESCENT DYE LABELED PROBES, 2018-2030 (USD MILLION)
TABLE 61. BRAZIL FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY PROBE DESIGN, 2018-2030 (USD MILLION)
TABLE 62. CANADA FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 63. CANADA FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 64. CANADA FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY CANCER DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 65. CANADA FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 66. CANADA FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 67. CANADA FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 68. CANADA FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY NON-FLUORESCENT DYE LABELED PROBES, 2018-2030 (USD MILLION)
TABLE 69. CANADA FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY PROBE DESIGN, 2018-2030 (USD MILLION)
TABLE 70. MEXICO FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 71. MEXICO FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 72. MEXICO FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY CANCER DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 73. MEXICO FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 74. MEXICO FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 75. MEXICO FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 76. MEXICO FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY NON-FLUORESCENT DYE LABELED PROBES, 2018-2030 (USD MILLION)
TABLE 77. MEXICO FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY PROBE DESIGN, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY CANCER DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY NON-FLUORESCENT DYE LABELED PROBES, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY PROBE DESIGN, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 87. ASIA-PACIFIC FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 88. ASIA-PACIFIC FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. ASIA-PACIFIC FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY CANCER DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 90. ASIA-PACIFIC FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 91. ASIA-PACIFIC FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 92. ASIA-PACIFIC FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 93. ASIA-PACIFIC FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY NON-FLUORESCENT DYE LABELED PROBES, 2018-2030 (USD MILLION)
TABLE 94. ASIA-PACIFIC FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY PROBE DESIGN, 2018-2030 (USD MILLION)
TABLE 95. ASIA-PACIFIC FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 96. AUSTRALIA FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 97. AUSTRALIA FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. AUSTRALIA FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY CANCER DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 99. AUSTRALIA FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 100. AUSTRALIA FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 101. AUSTRALIA FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 102. AUSTRALIA FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY NON-FLUORESCENT DYE LABELED PROBES, 2018-2030 (USD MILLION)
TABLE 103. AUSTRALIA FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY PROBE DESIGN, 2018-2030 (USD MILLION)
TABLE 104. CHINA FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 105. CHINA FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 106. CHINA FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY CANCER DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 107. CHINA FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 108. CHINA FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 109. CHINA FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 110. CHINA FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY NON-FLUORESCENT DYE LABELED PROBES, 2018-2030 (USD MILLION)
TABLE 111. CHINA FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY PROBE DESIGN, 2018-2030 (USD MILLION)
TABLE 112. INDIA FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 113. INDIA FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 114. INDIA FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY CANCER DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 115. INDIA FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 116. INDIA FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 117. INDIA FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 118. INDIA FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY NON-FLUORESCENT DYE LABELED PROBES, 2018-2030 (USD MILLION)
TABLE 119. INDIA FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY PROBE DESIGN, 2018-2030 (USD MILLION)
TABLE 120. INDONESIA FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 121. INDONESIA FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. INDONESIA FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY CANCER DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 123. INDONESIA FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 124. INDONESIA FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 125. INDONESIA FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 126. INDONESIA FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY NON-FLUORESCENT DYE LABELED PROBES, 2018-2030 (USD MILLION)
TABLE 127. INDONESIA FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY PROBE DESIGN, 2018-2030 (USD MILLION)
TABLE 128. JAPAN FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 129. JAPAN FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 130. JAPAN FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY CANCER DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 131. JAPAN FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 132. JAPAN FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 133. JAPAN FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 134. JAPAN FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY NON-FLUORESCENT DYE LABELED PROBES, 2018-2030 (USD MILLION)
TABLE 135. JAPAN FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY PROBE DESIGN, 2018-2030 (USD MILLION)
TABLE 136. MALAYSIA FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 137. MALAYSIA FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 138. MALAYSIA FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY CANCER DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 139. MALAYSIA FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 140. MALAYSIA FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 141. MALAYSIA FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 142. MALAYSIA FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY NON-FLUORESCENT DYE LABELED PROBES, 2018-2030 (USD MILLION)
TABLE 143. MALAYSIA FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY PROBE DESIGN, 2018-2030 (USD MILLION)
TABLE 144. PHILIPPINES FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 145. PHILIPPINES FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. PHILIPPINES FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY CANCER DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 147. PHILIPPINES FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 148. PHILIPPINES FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 149. PHILIPPINES FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 150. PHILIPPINES FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY NON-FLUORESCENT DYE LABELED PROBES, 2018-2030 (USD MILLION)
TABLE 151. PHILIPPINES FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY PROBE DESIGN, 2018-2030 (USD MILLION)
TABLE 152. SINGAPORE FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 153. SINGAPORE FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 154. SINGAPORE FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY CANCER DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 155. SINGAPORE FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 156. SINGAPORE FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 157. SINGAPORE FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 158. SINGAPORE FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY NON-FLUORESCENT DYE LABELED PROBES, 2018-2030 (USD MILLION)
TABLE 159. SINGAPORE FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY PROBE DESIGN, 2018-2030 (USD MILLION)
TABLE 160. SOUTH KOREA FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 161. SOUTH KOREA FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 162. SOUTH KOREA FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY CANCER DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 163. SOUTH KOREA FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 164. SOUTH KOREA FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 165. SOUTH KOREA FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 166. SOUTH KOREA FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY NON-FLUORESCENT DYE LABELED PROBES, 2018-2030 (USD MILLION)
TABLE 167. SOUTH KOREA FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY PROBE DESIGN, 2018-2030 (USD MILLION)
TABLE 168. TAIWAN FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 169. TAIWAN FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 170. TAIWAN FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY CANCER DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 171. TAIWAN FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 172. TAIWAN FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 173. TAIWAN FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 174. TAIWAN FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY NON-FLUORESCENT DYE LABELED PROBES, 2018-2030 (USD MILLION)
TABLE 175. TAIWAN FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY PROBE DESIGN, 2018-2030 (USD MILLION)
TABLE 176. THAILAND FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 177. THAILAND FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 178. THAILAND FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY CANCER DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 179. THAILAND FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 180. THAILAND FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 181. THAILAND FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 182. THAILAND FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY NON-FLUORESCENT DYE LABELED PROBES, 2018-2030 (USD MILLION)
TABLE 183. THAILAND FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY PROBE DESIGN, 2018-2030 (USD MILLION)
TABLE 184. VIETNAM FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 185. VIETNAM FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 186. VIETNAM FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY CANCER DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 187. VIETNAM FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 188. VIETNAM FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 189. VIETNAM FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 190. VIETNAM FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY NON-FLUORESCENT DYE LABELED PROBES, 2018-2030 (USD MILLION)
TABLE 191. VIETNAM FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY PROBE DESIGN, 2018-2030 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY CANCER DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY NON-FLUORESCENT DYE LABELED PROBES, 2018-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY PROBE DESIGN, 2018-2030 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 201. DENMARK FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 202. DENMARK FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 203. DENMARK FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY CANCER DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 204. DENMARK FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 205. DENMARK FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 206. DENMARK FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 207. DENMARK FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY NON-FLUORESCENT DYE LABELED PROBES, 2018-2030 (USD MILLION)
TABLE 208. DENMARK FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY PROBE DESIGN, 2018-2030 (USD MILLION)
TABLE 209. EGYPT FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 210. EGYPT FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 211. EGYPT FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY CANCER DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 212. EGYPT FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 213. EGYPT FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 214. EGYPT FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 215. EGYPT FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY NON-FLUORESCENT DYE LABELED PROBES, 2018-2030 (USD MILLION)
TABLE 216. EGYPT FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY PROBE DESIGN, 2018-2030 (USD MILLION)
TABLE 217. FINLAND FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 218. FINLAND FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 219. FINLAND FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY CANCER DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 220. FINLAND FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 221. FINLAND FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 222. FINLAND FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 223. FINLAND FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY NON-FLUORESCENT DYE LABELED PROBES, 2018-2030 (USD MILLION)
TABLE 224. FINLAND FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY PROBE DESIGN, 2018-2030 (USD MILLION)
TABLE 225. FRANCE FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 226. FRANCE FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 227. FRANCE FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY CANCER DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 228. FRANCE FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 229. FRANCE FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 230. FRANCE FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 231. FRANCE FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY NON-FLUORESCENT DYE LABELED PROBES, 2018-2030 (USD MILLION)
TABLE 232. FRANCE FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY PROBE DESIGN, 2018-2030 (USD MILLION)
TABLE 233. GERMANY FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 234. GERMANY FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 235. GERMANY FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY CANCER DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 236. GERMANY FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 237. GERMANY FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 238. GERMANY FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 239. GERMANY FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY NON-FLUORESCENT DYE LABELED PROBES, 2018-2030 (USD MILLION)
TABLE 240. GERMANY FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY PROBE DESIGN, 2018-2030 (USD MILLION)
TABLE 241. ISRAEL FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 242. ISRAEL FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 243. ISRAEL FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY CANCER DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 244. ISRAEL FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 245. ISRAEL FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 246. ISRAEL FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 247. ISRAEL FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY NON-FLUORESCENT DYE LABELED PROBES, 2018-2030 (USD MILLION)
TABLE 248. ISRAEL FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY PROBE DESIGN, 2018-2030 (USD MILLION)
TABLE 249. ITALY FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 250. ITALY FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 251. ITALY FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY CANCER DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 252. ITALY FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 253. ITALY FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 254. ITALY FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 255. ITALY FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY NON-FLUORESCENT DYE LABELED PROBES, 2018-2030 (USD MILLION)
TABLE 256. ITALY FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY PROBE DESIGN, 2018-2030 (USD MILLION)
TABLE 257. NETHERLANDS FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 258. NETHERLANDS FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 259. NETHERLANDS FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY CANCER DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 260. NETHERLANDS FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 261. NETHERLANDS FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 262. NETHERLANDS FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 263. NETHERLANDS FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY NON-FLUORESCENT DYE LABELED PROBES, 2018-2030 (USD MILLION)
TABLE 264. NETHERLANDS FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY PROBE DESIGN, 2018-2030 (USD MILLION)
TABLE 265. NIGERIA FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 266. NIGERIA FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 267. NIGERIA FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY CANCER DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 268. NIGERIA FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 269. NIGERIA FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 270. NIGERIA FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 271. NIGERIA FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY NON-FLUORESCENT DYE LABELED PROBES, 2018-2030 (USD MILLION)
TABLE 272. NIGERIA FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY PROBE DESIGN, 2018-2030 (USD MILLION)
TABLE 273. NORWAY FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 274. NORWAY FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 275. NORWAY FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY CANCER DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 276. NORWAY FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 277. NORWAY FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 278. NORWAY FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 279. NORWAY FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY NON-FLUORESCENT DYE LABELED PROBES, 2018-2030 (USD MILLION)
TABLE 280. NORWAY FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY PROBE DESIGN, 2018-2030 (USD MILLION)
TABLE 281. POLAND FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 282. POLAND FLUORESCENCE IN SITU HYBRIDIZATION PROBE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 283. POLAND FLUORESCENCE IN SITU HYBRIDIZAT

Companies Mentioned

The leading players in the Fluorescence In Situ Hybridization Probe Market, which are profiled in this report, include:
  • Abbott Laboratories
  • Agilent Technologies
  • Bio-Rad Laboratories
  • Bio-Techne Corporation
  • Biosearch Technologies
  • Enzo Life Sciences
  • Exiqon
  • F. Hoffmann-La Roche
  • Geneco Biomedical Products
  • GeneCopoeia
  • GlaxoSmithKline
  • Horizon Diagnostics
  • LabCorp
  • Leica Biosystems
  • Merck Group
  • NeoGenomics Laboratories
  • OxFord Gene Technology
  • PerkinElmer
  • Thermo Fisher Scientific
  • Zymo Research

Methodology

Loading
LOADING...

Table Information